Photonics firms' chance to make a big difference on green issues
8 November 2019
Tematys partner Benoît d’Humières discusses photonics’ environmental potential using findings from a recent sustainability report
Tematys
Horizon 2020 to create 3,500 high-tech jobs
7 November 2019
A new survey has found that 100 Horizon 2020 photonics projects will create 3,500 high-tech jobs in Europe over the next three years
Photoacoustic imaging to hit $240m in 2022 with move into clinic
24 March 2017
The photoacoustic imaging (PAI) market is expected to reach $240 million in 2022, driven by its translation into clinical applications, new analysis suggests
Miniature spectrometers sector to overtake overall systems market
7 December 2016
The miniaturised spectrometers sector is set to reach almost $300 million by 2021, growing faster than the overall molecular spectrometer systems market, according to a new market report by Tematys
Terahertz market to reach €98 million in 2020
22 July 2016
The terahertz technology market is expected to grow from €46 million in 2015 to €98 million in 2020, at CAGR of 16 per cent, according to a new report by photonics market research firm Tematys
Mergers and acquisitions: good for photonics?
11 May 2016
Several high profile acquisitions have been made in the last few months in the photonics sector. Thierry Robin and Jacques Cochard from Tematys discuss the impact of mergers and acquisitions on the photonics industry
Driver assistance to represent €9bn market for photonics by 2020, says Tematys
8 April 2015
As cars start to include more onboard smart and safety functionality, the opportunities for photonics in the automotive sector look set to increase, writes Clémentine Bouyé and Jacques Cochard at market research firm Tematys
Road to the clinic: opportunities in biophotonics
6 January 2014
Turning biophotonic technologies into a clinical device is a long and difficult road. Jacques Cochard, Tematys founder, reports from the European Photonics Industry Consortium's (EPIC) biophotonics event, entitled 'optimising the road to clinical products', which took place 27-28 November 2013 at the Maastricht University Medical Center in The Netherlands
